Maribavir Patent Expiration
Maribavir is Used for treating post-transplant cytomegalovirus (CMV) infection/disease refractory to other antiviral treatments in stem cell, kidney, or liver transplant recipients. It was first introduced by Takeda Pharmaceuticals Usa Inc
Maribavir Patents
Given below is the list of patents protecting Maribavir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Livtencity | US12213989 | Use of maribavir in treatment regimens | Nov 18, 2042 | Takeda Pharms Usa |
| Livtencity | US11684632 | Maribavir isomers, compositions, methods of making and methods of using | Jan 04, 2032 | Takeda Pharms Usa |
Maribavir's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List